Tularik: Clinical Trials

1 trial sponsored by Tularik, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow Tularik: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients
T138067 intravenous, doxorubicin intravenous - Hepatocellular Carcinoma
Phase 2 / Phase 3TerminatedTularik7502003-03-012005-06-24

Conditions studied

Carcinoma, Hepatocellular (1)  ·  Liver Neoplasms (1)

Countries

Brazil (1)  ·  China (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Russia (1)  ·  Singapore (1)  ·  South Africa (1)  ·  Thailand (1)  ·  Ukraine (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Mohammad Hirmand, MD (1)